Eschler Asset Management LLP Immunocore Holdings PLC Transaction History

Eschler Asset Management LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$42.85 - $69.5 $428,500 - $695,000	10,000 Added 33.33%	40,000 $2.73 Million
Q3 2023 Nov 14, 2023	SELL	$49.5 - $66.6 $198,000 - $266,400	-4,000 Reduced 11.76%	30,000 $1.56 Million
Q2 2023 Aug 11, 2023	SELL	$48.54 - $61.64 $1.26 Million - $1.6 Million	-26,000 Reduced 43.33%	34,000 $2.04 Million
Q1 2023 May 15, 2023	BUY	$46.12 - $65.71 $1.29 Million - $1.84 Million	28,000 Added 87.5%	60,000 $2.97 Million
Q4 2022 Feb 14, 2023	BUY	$45.51 - $65.08 $546,120 - $780,960	12,000 Added 60.0%	32,000 $1.83 Million
Q3 2022 Nov 14, 2022	BUY	$37.34 - $57.44 $746,800 - $1.15 Million	20,000 New	20,000 $939,000

141

41.4M

197K

451K

Ticker IMCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,897,100
Market Cap $1.24B
Description
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...

Get notified when there are updates to the investment portfolio of Eschler Asset Management LLP, based on Form 13F filings with the SEC.

Stay updated on Eschler Asset Management LLP with notifications on news.